Kent L. Nastiuk, Ph.D.

Kent L. Nastiuk, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester, NY 14642

Office: (585) 276--628
Fax: (585) 276--227

Bio

Dr. Nastiuk's biographical information is not currently available.

Recent Journal Articles

Showing the 5 most recent journal articles. 20 available »

2012 Jul
Pioli PD, Saleh AM, El Fiky A, Nastiuk KL, Krolewski JJ. "Sequential proteolytic processing of an interferon-alpha receptor subunit by TNF-alpha converting enzyme and presenilins." Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2012 Jul 0; 32(7):312-25. Epub 2012 Mar 29.
2011 Apr
Davis JS, Nastiuk KL, Krolewski JJ. "TNF is necessary for castration-induced prostate regression, whereas TRAIL and FasL are dispensable." Molecular endocrinology (Baltimore, Md.). 2011 Apr 0; 25(4):611-20. Epub 2011 Feb 03.
2009 Feb 15
Yoo KS, Nastiuk KL, Krolewski JJ. "Transforming growth factor beta1 induces apoptosis by suppressing FLICE-like inhibitory protein in DU145 prostate epithelial cells." International journal of cancer. Journal international du cancer. 2009 Feb 15; 124(4):834-42.
2008 Aug
Nastiuk KL, Krolewski JJ. "FLIP-ping out: death receptor signaling in the prostate." Cancer biology & therapy. 2008 Aug 0; 7(8):1171-9. Epub 2008 Aug 01.
2008 Jul 24
Cornforth AN, Davis JS, Khanifar E, Nastiuk KL, Krolewski JJ. "FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells." Oncogene. 2008 Jul 24; 27(32):4422-33. Epub 2008 Apr 07.

Current Appointments

Interim Associate Professor - Department of Pathology and Laboratory Medicine (SMD) - Primary

Education

PhD | Molecular Neuroendocrinology | The Rockfeller University1992
A.B. with High Honors in Psychobiology | Oberlin College1985